ABCG2 and small cell lung carcinoma: As ABCG2 is YAP/TAZ transcriptional target gene, enriched SCLC cells were treated with YAP/TAZ-TEAD specific inhibitor MGH-CP1 in presence or absence of ABCG2 substrate drugs doxorubicin and etoposide.